Home
Categories
Submit Press Release
Order Credits
Archive
10242016 09:50 AM CET Business, Economy, Finances, Banking & Insurance
News / Feeds
Global Losartan Potassium Market 2016 Hanmi Fine Chemical, Merck, Teva Pharmaceutical, Taj Pharmaceuticals, Zhejiang Tianyu, Shanghai Pharma Xinya, Shandong Xinyi Press release from: Fior Markets
Losartan is an angiotensin II receptor antagonist drug used mainly to treat high blood pressure (hypertension). It was the first angiotensin II antagonist to be marketed. Losartan potassium is marketed by Merck & Co. Inc. under the trade name Cozaar, and is available in generic form. Request for sample report at www.fiormarkets.com/report detail/10890/requestsample This report provides detailed analysis of worldwide markets for Losartan Potassium from 20112015 and provides extensive market forecasts 2016 2021 by region/country and subsectors. It covers the key technological and market trends in the Losartan Potassium market and further lays out an analysis of the factors influencing the supply/demand for Losartan Potassium, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies. Global Losartan Potassium Market Outlook 20162021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Losartan Potassium market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. Access full report at www.fiormarkets.com/report/globallosartanpotassiummark... The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Losartan Potassium market are Hanmi Fine Chemical (Korea), Merck (USA), Teva Pharmaceutical (Israel), Taj Pharmaceuticals (India), Zhejiang Tianyu (China), Shanghai Pharma Xinya (China), Shandong Xinyi (China), among others. The report provides separate comprehensive analytics for the North America, Europe, AsiaPacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Losartan Potassium industry has been provided.
About Us
GO
Search
More Releases from Fior Markets Global Sodium Ligninsulfonate Market 2016 Borregaard Karjala Pulp Tembec MeadWestvaco Kondopoga CWZ Tianjin Yezi Global Sodium Hydrosulfide Market 2016 Sankyo Kasei MGC Cashihor Zimi Chemical Henan Tianshui Zibo Pulisi Global Sodium Cyanide market 2016 Dupont Evonik Nippon Soda Showa Denko Tongsuh Petro Taekwang Ind Sasol Orica Cyanco Anhui Shuguang Hebei Chengxin All 785 Releases
Comments about openPR 9 o'clock: discuss press release with client 10 o'clock: submit release to openPR Within the briefest possible time release is published and displayed in a prominent place on openPR.de. I am thrilled! Zehra Spindler, Calypso Now! Communication Agency
Your Press Releases on Google News
Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hitech systems and current processing systems in its expertise.
openPR.de
Contact Us Mark Stone Sales Manager Phone: (201) 4654211 Email: sales@fiormarkets.com Web: www.fiormarkets.com Blog: longshortreport.com/ This release was published on openPR.
NewsID: 375593 More releases
Permanent link to this press release: http://www.openpr.com/news/375593/GlobalLosartanPotassiumMarket2016HanmiFineChemicalMerckTevaPharmaceuticalTajPharmaceuticalsZhejiangTianyuShanghaiPharmaXinyaShandon Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release here:
Delete press release
Edit press release